These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34639841)

  • 21. Applied tension and coping with blood donation: a randomized trial.
    Holly CD; Torbit L; Ditto B
    Ann Behav Med; 2012 Apr; 43(2):173-80. PubMed ID: 22016263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse.
    Trouern-Trend JJ; Cable RG; Badon SJ; Newman BH; Popovsky MA
    Transfusion; 1999 Mar; 39(3):316-20. PubMed ID: 10204597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasovagal reactions in blood donors: risks, prevention and management.
    Thijsen A; Masser B
    Transfus Med; 2019 Apr; 29 Suppl 1():13-22. PubMed ID: 29148259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-time whole blood donation: A critical step for donor safety and retention on first three donations.
    Gillet P; Rapaille A; Benoît A; Ceinos M; Bertrand O; de Bouyalsky I; Govaerts B; Lambermont M
    Transfus Clin Biol; 2015; 22(5-6):312-7. PubMed ID: 26476508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using the Health Action Process Approach to predict blood donation intentions and return behavior following a vasovagal reaction for whole blood and plasma donors.
    Thijsen A; Gemelli CN; Davison TE; Masser B
    Transfusion; 2022 Sep; 62(9):1791-1798. PubMed ID: 35924722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Elevated Hemoglobin and Serum Protein on Vasovagal Reaction from Blood Donation.
    Odajima T; Takanashi M; Sugimori H; Tanba T; Yoshinaga K; Motoji T; Munakata M; Nakajima K; Minami M
    PLoS One; 2016; 11(2):e0148854. PubMed ID: 26894814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in return behavior after an adverse event in Australian whole blood and plasma donors.
    Thijsen A; Masser B; Gemelli CN; Davison TE
    Transfusion; 2019 Oct; 59(10):3157-3163. PubMed ID: 31403178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved donor safety in high-volume apheresis collections.
    Vassallo RR; Bravo MD; Kamel H
    Transfusion; 2017 Feb; 57(2):319-324. PubMed ID: 27861957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single-centre study of vasovagal reaction in blood donors: Influence of age, sex, donation status, weight, total blood volume and volume of blood collected.
    Philip J; Sarkar RS; Jain N
    Asian J Transfus Sci; 2014 Jan; 8(1):43-6. PubMed ID: 24678174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasovagal reactions in 'at risk' donors: a univariate analysis of effect of age and weight on the grade of donor reactions.
    Tondon R; Pandey P; Chaudhary R
    Transfus Apher Sci; 2008 Oct; 39(2):95-9. PubMed ID: 18753009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events.
    Thijsen A; Davison TE; Speedy J; Hoad V; Masser B
    Vox Sang; 2021 Mar; 116(3):273-280. PubMed ID: 32702163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of applied muscle tension on cerebral oxygenation in female blood donors.
    Kowalsky JM; France JL; Wissel ME; France CR
    Transfusion; 2011 Aug; 51(8):1802-8. PubMed ID: 21382044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determining the effect of vein visualization technology on donation success, vasovagal symptoms, anxiety and intention to re-donate in whole blood donors aged 18-30 years: A randomized controlled trial.
    Waller D; Mondy P; Brama T; Fisher J; King A; Malkov K; Wall-Smith D; Ryan L; Irving DO
    Vox Sang; 2016 Aug; 111(2):135-43. PubMed ID: 27167612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications of blood donation reported to haemovigilance systems: analysis of eleven years of international surveillance.
    Wiersum-Osselton JC; Politis C; Richardson C; Goto N; Grouzi E; Marano G; Land KJ
    Vox Sang; 2021 Jul; 116(6):628-636. PubMed ID: 33278040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasovagal reactions in blood donors during or immediately after blood donation.
    Zervou EK; Ziciadis K; Karabini F; Xanthi E; Chrisostomou E; Tzolou A
    Transfus Med; 2005 Oct; 15(5):389-94. PubMed ID: 16202053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lost in translation: Knowledge, attitudes and practices in donors experiencing a vasovagal reaction.
    Thijsen A; King A; Waller D
    Transfus Apher Sci; 2016 Jun; 54(3):384-9. PubMed ID: 26704301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fear of blood draw and total draw time combine to predict vasovagal reactions among whole blood donors.
    France CR; France JL; Frame-Brown TA; Venable GA; Menitove JE
    Transfusion; 2016 Jan; 56(1):179-85. PubMed ID: 26264764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing reactions to blood donation with applied muscle tension: a randomized controlled trial.
    Ditto B; France CR; Lavoie P; Roussos M; Adler PS
    Transfusion; 2003 Sep; 43(9):1269-75. PubMed ID: 12919430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Delayed adverse reactions to blood donation: From haemovigilance data to specific studies].
    Py JY; Durieux S; Barnoux M; Sapey T
    Transfus Clin Biol; 2016 Nov; 23(4):233-239. PubMed ID: 27769684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologic strategies to prevent fainting responses during or after whole blood donation.
    Wieling W; France CR; van Dijk N; Kamel H; Thijs RD; Tomasulo P
    Transfusion; 2011 Dec; 51(12):2727-38. PubMed ID: 21645008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.